Literature DB >> 15283894

The science of early detection.

Barnett S Kramer1.   

Abstract

Most clinical judgment and clinical intuition derives from observations made on patients who suffer from a disease or medical condition. However, the target population for cancer screening is healthy people who would not seek out a health professional unless convinced to do so by advertising or public messages. Extrapolation of clinical observations to the target population for screening can be very misleading and even harmful. This is because powerful screening biases and confounding effects--such as selection bias, lead-time bias, length-bias sampling, and overdiagnosis--can mislead even the most astute clinician. This article will discuss those biases, review methods to avoid them, and provide useful resources to the clinician or health scientist. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15283894     DOI: 10.1016/j.urolonc.2003.04.001

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  9 in total

Review 1.  Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.

Authors:  Sudhir Srivastava; Brian J Reid; Sharmistha Ghosh; Barnett S Kramer
Journal:  J Cell Physiol       Date:  2016-04-29       Impact factor: 6.384

Review 2.  Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.

Authors:  Jesse D Sammon; Firas Abdollah; Anthony D'Amico; Matthew Gettman; Alexander Haese; Nazareno Suardi; Andrew Vickers; Quoc-Dien Trinh
Journal:  Eur Urol       Date:  2015-03-26       Impact factor: 20.096

3.  Long-Term Lithium Use and Risk of Renal and Upper Urinary Tract Cancers.

Authors:  Anton Pottegård; Jesper Hallas; Boye L Jensen; Kirsten Madsen; Søren Friis
Journal:  J Am Soc Nephrol       Date:  2015-05-04       Impact factor: 10.121

4.  Estimating patient health in prostate cancer treatment counseling.

Authors:  Gregory T Chesnut; Amy L Tin; Katherine A Fleshner; Nicole E Benfante; Andrew J Vickers; James A Eastham; Daniel D Sjoberg; Sigrid V Carlsson
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-11-03       Impact factor: 5.554

5.  Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line.

Authors:  Shiaw-Lin Wu; Allen D Taylor; Qiaozhen Lu; Samir M Hanash; Hogune Im; Michael Snyder; William S Hancock
Journal:  Mol Cell Proteomics       Date:  2013-01-31       Impact factor: 5.911

Review 6.  The implications of ageing and life expectancy in prostate cancer treatment.

Authors:  Sarathi Kalra; Spyridon Basourakos; Angela Abouassi; Mary Achim; Robert J Volk; Karen E Hoffman; John W Davis; Jeri Kim
Journal:  Nat Rev Urol       Date:  2016-03-22       Impact factor: 14.432

Review 7.  Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development (carcino-evo-devo).

Authors:  A P Kozlov
Journal:  Infect Agent Cancer       Date:  2022-01-10       Impact factor: 2.965

8.  Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease.

Authors:  M W M D Lutgens; B Oldenburg; P D Siersema; A A van Bodegraven; G Dijkstra; D W Hommes; D J de Jong; P C F Stokkers; C J van der Woude; F P Vleggaar
Journal:  Br J Cancer       Date:  2009-10-13       Impact factor: 7.640

9.  Comparative miRNAome analysis revealed different miRNA expression profiles in bovine sera and exosomes.

Authors:  Ke Zhao; Guanxiang Liang; Xu Sun; Le Luo Guan
Journal:  BMC Genomics       Date:  2016-08-12       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.